Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137210918> ?p ?o ?g. }
- W2137210918 abstract "To analyze and compare the economic outcomes of adjuvant chemotherapy with capecitabine plus oxaliplatin (referred to as the XELOX strategy) and of S-1 (the S-1 strategy) for gastric cancer patients after D2 gastrectomy. A Markov model was developed to simulate the lifetime disease course associated with stage II or III gastric cancer after D2 gastrectomy. The lifetime quality-adjusted life years (QALYs), associated costs, and incremental cost-effectiveness ratios (ICERs) were estimated. The clinical data were derived from the results of pilot studies. Direct costs were estimated from the perspective of the Chinese healthcare system, and the utility data were measured from end-point observations of Chinese patients. Sensitivity analyses were used to explore the impact of uncertainty on the model’s outcomes. The combined adjuvant chemotherapy strategy with XELOX yielded the greatest increase in QALYs over the course of the disease (8.1 QALYs compared with 7.8 QALYs for the S-1 strategy and 6.2 for surgery alone). The incremental cost per QALY gained using the XELOX strategy was significantly lower than that for the S-1 strategy ($3,502 vs. $6,837, respectively). The results were sensitive to the costs of oxaliplatin and the hazard ratio of relapse-free survival. The observations reported herein suggest that adjuvant therapy with capecitabine plus oxaliplatin is a highly cost-effective strategy and more favorable treatment option than the S-1 strategy in patients with stage II or III gastric cancer who have undergone D2 gastrectomy." @default.
- W2137210918 created "2016-06-24" @default.
- W2137210918 creator A5017090255 @default.
- W2137210918 creator A5039038654 @default.
- W2137210918 creator A5045040327 @default.
- W2137210918 creator A5052564248 @default.
- W2137210918 creator A5067373934 @default.
- W2137210918 date "2014-12-01" @default.
- W2137210918 modified "2023-09-25" @default.
- W2137210918 title "Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy" @default.
- W2137210918 cites W12636511 @default.
- W2137210918 cites W1977373411 @default.
- W2137210918 cites W1983579026 @default.
- W2137210918 cites W1995517770 @default.
- W2137210918 cites W1995622300 @default.
- W2137210918 cites W1997903200 @default.
- W2137210918 cites W2007130843 @default.
- W2137210918 cites W2009076418 @default.
- W2137210918 cites W2015966451 @default.
- W2137210918 cites W2023715075 @default.
- W2137210918 cites W2026986976 @default.
- W2137210918 cites W2032689844 @default.
- W2137210918 cites W2042594167 @default.
- W2137210918 cites W2047783753 @default.
- W2137210918 cites W2058257609 @default.
- W2137210918 cites W2062951653 @default.
- W2137210918 cites W2068411642 @default.
- W2137210918 cites W2069813038 @default.
- W2137210918 cites W2077902459 @default.
- W2137210918 cites W2087108889 @default.
- W2137210918 cites W2087172906 @default.
- W2137210918 cites W2098719201 @default.
- W2137210918 cites W2100439220 @default.
- W2137210918 cites W2106638985 @default.
- W2137210918 cites W2106787323 @default.
- W2137210918 cites W2110941552 @default.
- W2137210918 cites W2113947048 @default.
- W2137210918 cites W2114043825 @default.
- W2137210918 cites W2115072149 @default.
- W2137210918 cites W2122879222 @default.
- W2137210918 cites W2123759725 @default.
- W2137210918 cites W2133593152 @default.
- W2137210918 cites W2137991416 @default.
- W2137210918 cites W2143908827 @default.
- W2137210918 cites W2147035058 @default.
- W2137210918 cites W2152225451 @default.
- W2137210918 cites W2170085958 @default.
- W2137210918 cites W2397419887 @default.
- W2137210918 cites W2406146824 @default.
- W2137210918 cites W24653448 @default.
- W2137210918 cites W4237204919 @default.
- W2137210918 doi "https://doi.org/10.1186/1471-2407-14-984" @default.
- W2137210918 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4301844" @default.
- W2137210918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25526802" @default.
- W2137210918 hasPublicationYear "2014" @default.
- W2137210918 type Work @default.
- W2137210918 sameAs 2137210918 @default.
- W2137210918 citedByCount "44" @default.
- W2137210918 countsByYear W21372109182016 @default.
- W2137210918 countsByYear W21372109182017 @default.
- W2137210918 countsByYear W21372109182018 @default.
- W2137210918 countsByYear W21372109182019 @default.
- W2137210918 countsByYear W21372109182020 @default.
- W2137210918 countsByYear W21372109182021 @default.
- W2137210918 countsByYear W21372109182022 @default.
- W2137210918 countsByYear W21372109182023 @default.
- W2137210918 crossrefType "journal-article" @default.
- W2137210918 hasAuthorship W2137210918A5017090255 @default.
- W2137210918 hasAuthorship W2137210918A5039038654 @default.
- W2137210918 hasAuthorship W2137210918A5045040327 @default.
- W2137210918 hasAuthorship W2137210918A5052564248 @default.
- W2137210918 hasAuthorship W2137210918A5067373934 @default.
- W2137210918 hasBestOaLocation W21372109181 @default.
- W2137210918 hasConcept C112930515 @default.
- W2137210918 hasConcept C121608353 @default.
- W2137210918 hasConcept C126322002 @default.
- W2137210918 hasConcept C141071460 @default.
- W2137210918 hasConcept C143998085 @default.
- W2137210918 hasConcept C207103383 @default.
- W2137210918 hasConcept C2777909004 @default.
- W2137210918 hasConcept C2780140570 @default.
- W2137210918 hasConcept C2780470880 @default.
- W2137210918 hasConcept C2780962732 @default.
- W2137210918 hasConcept C3019080777 @default.
- W2137210918 hasConcept C44249647 @default.
- W2137210918 hasConcept C526805850 @default.
- W2137210918 hasConcept C64332521 @default.
- W2137210918 hasConcept C71924100 @default.
- W2137210918 hasConceptScore W2137210918C112930515 @default.
- W2137210918 hasConceptScore W2137210918C121608353 @default.
- W2137210918 hasConceptScore W2137210918C126322002 @default.
- W2137210918 hasConceptScore W2137210918C141071460 @default.
- W2137210918 hasConceptScore W2137210918C143998085 @default.
- W2137210918 hasConceptScore W2137210918C207103383 @default.
- W2137210918 hasConceptScore W2137210918C2777909004 @default.
- W2137210918 hasConceptScore W2137210918C2780140570 @default.
- W2137210918 hasConceptScore W2137210918C2780470880 @default.
- W2137210918 hasConceptScore W2137210918C2780962732 @default.
- W2137210918 hasConceptScore W2137210918C3019080777 @default.
- W2137210918 hasConceptScore W2137210918C44249647 @default.